Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 6
Submit an article Journal homepage
2,669
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children

Natividad Viguriaa Department of Paediatrics, Complejo Hospitalario de Navarra – IdiSNA, Pamplona, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0920-5072View further author information
ORCID Icon,
Ana Navascuésb Department of Clinical Microbiology, Complejo Hospitalario de Navarra – IdiSNA, Pamplona, SpainView further author information
,
Regina Juanbeltzc Department of Hospital Pharmacy, Complejo Hospitalario de Navarra – IdiSNA, Pamplona, Spain;d CIBER Epidemiología y Salud Pública (CIBERESP), SpainView further author information
,
Alberto Echeverríae Centro de Atención Primaria (CAP) de Aoiz, Navarra, SpainORCID Iconhttps://orcid.org/0000-0002-1574-4534View further author information
ORCID Icon,
Carmen Ezpeletab Department of Clinical Microbiology, Complejo Hospitalario de Navarra – IdiSNA, Pamplona, SpainView further author information
&
Jesús Castillad CIBER Epidemiología y Salud Pública (CIBERESP), Spain;f Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, SpainORCID Iconhttps://orcid.org/0000-0002-6396-7265View further author information
ORCID Icon
Pages 1867-1872 | Received 31 Jul 2020, Accepted 24 Oct 2020, Published online: 27 Jan 2021

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Catherine Weil-Olivier, David Salisbury, José Antonio Navarro-Alonso, Chryssoula Tzialla, Yan Zhang, Susanna Esposito, Fabio Midulla & Tobias Tenenbaum. (2023) Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections. Human Vaccines & Immunotherapeutics 19:1.
Read now
Eugenio Baraldi, Giovanni Checcucci Lisi, Claudio Costantino, Jon H. Heinrichs, Paolo Manzoni, Matteo Riccò, Michelle Roberts & Natalya Vassilouthis. (2022) RSV disease in infants and young children: Can we see a brighter future?. Human Vaccines & Immunotherapeutics 18:4.
Read now

Articles from other publishers (11)

Francesca Parola, Adalberto Brach del Prever, Virginia Deut, Giulia Costagliola, Carla Guidi, Neftj Ragusa, Antonella Tuscano, Fabio Timeus & Massimo Berger. (2024) Impact of SARS-CoV-2 Pandemic and Lockdown on the HRSV Circulation: Experience of Three Spoke Hospitals in Northern Italy. Viruses 16:2, pages 230.
Crossref
Khaled El-Atawi, Daniele De Luca, Ranagasamy Ramanathan, Manuel Sanchez Luna, Saad Alsaedi, Muzafar Gani Abdul Wahab, Moataz Hamdi & Maysa Saleh. (2023) Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis. Cureus.
Crossref
Rupali J Limaye, Molly Sauer, Rosemary Njogu, Prachi Singh, Berhaun Fesshaye & Ruth A Karron. (2023) Characterizing Attitudes Toward Maternal RSV Vaccines Among Pregnant and Lactating Persons in Kenya: Key Considerations for Demand Generation Efforts for Vaccine Acceptance. Journal of the Pediatric Infectious Diseases Society 12:12, pages 638-641.
Crossref
Rutger M. Schepp, Joanna Kaczorowska, Pieter G. M. van Gageldonk, Elsbeth D. M. Rouers, Elisabeth A. M. Sanders, Patricia C. J. Bruijning-Verhagen & Guy A. M. Berbers. (2023) Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands. Vaccines 11:12, pages 1807.
Crossref
Carlos A. Bueno, Franco M. Salinas, L. Vazquez, Laura E. Alché & Flavia M. Michelini. (2023) Two synthetic steroid analogs reduce human respiratory syncytial virus replication and the immune response to infection both in vitro and in vivo. Heliyon 9:10, pages e20148.
Crossref
Matteo Riccò, Silvia Corrado, Sara Palmieri & Federico Marchesi. (2023) Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022). Children 10:7, pages 1169.
Crossref
Lilian dos Santos Rodrigues Sadeck & Renato de Ávila Kfouri. (2023) An update on vaccination in preterm infants. Jornal de Pediatria 99, pages S81-S86.
Crossref
Matteo Riccò, Silvia Corrado, Milena Pia Cerviere, Silvia Ranzieri & Federico Marchesi. (2023) Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians. Pediatric Reports 15:1, pages 154-174.
Crossref
Tara Gonzales, Aurore Bergamasco, Tiffany Cristarella, Camille Goyer, Matthew Wojdyla, Abiola Oladapo, John Sawicky, John Yee & Yola Moride. (2022) Effectiveness and Safety of Palivizumab for the Prevention of Serious Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus: A Systematic Review. American Journal of Perinatology.
Crossref
Matteo Riccò, Pietro Ferraro, Silvia Corrado, Alessandro Zaniboni, Elia Satta & Silvia Ranzieri. (2022) Respiratory Syncytial Virus in Pregnant Women: Systematic Review and Meta-Analysis. Women 2:2, pages 147-160.
Crossref
Matteo Riccò, Pietro Ferraro, Simona Peruzzi, Alessandro Zaniboni & Silvia Ranzieri. (2022) Respiratory Syncytial Virus: Knowledge, Attitudes and Beliefs of General Practitioners from North-Eastern Italy (2021). Pediatric Reports 14:2, pages 147-165.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.